1Saetta M,Turato G,Maestrelli P,et al.Cellular and structural bases of chronic obstructive pulmonary disease.Am J Respir Crit Care Med,2001,163(6):1304-1309.
2Calverley P,Pauwels R,Vestbo J,et al.Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease:a randomised controlled trial.Lancet,2003,361(9356):449-456.
3Weersink EJ,Postma DS,Koeter GH,et al.Picumeterol:dissociation of improvement in lung function and reduction of airways hyperresponsiveness in asthmatics.Br J Clin Pharmacol,1997,43(2):169-176.
4Rohatagi S,Arya V,Zech K,et al.Population pharmacokinetics and pharmacodynamics of ciclesonide.J Clin Pharmacol,2003,43(4):365-378.
5Poole PJ,Black PN.Oral mucolytic drugs for exacerbations of chronic obstructive pulmonary disease:systematic review.BMJ,2001,322(7297):1271-1274.
6Kellerman DJ.P2Y(2) receptor agonists:a new class of medication targeted at improved mucociliary clearance.Chest,2002,121(5 Suppl):201S-205S.
8Dent G.Current Opinion in Investigational.Drugs,2002,3(1):78-83.
9Leung-Toung R,Li W,Tam TF,et al.Thiol-dependent enzymes and their inhibitors:a review.Curr Med Chem,2002,9(9):979-1002.
10Minematsu N,Nakamura H,Tateno H,et al.Genetic polymorphism in matrix met alloproteinase-9 and pulmonary emphysema.Biochem Biophys Res Commun,2001,289(1):116-119.
5Pauwels R.A, Buist AS, Calvedey PM, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary[ J]. Am J Respir Crit Care Med, 2001,163:1256 -76.
6Paggiaro PL, Dahle R, Bakran I,et al. Mnlticentre randomised placebocontrolled trial of inhaled flnticasone propionate in patients with chronic obstructive pulmonary disease. Lancet, 1998,351 : 773-780.
7Stewart DG, Drake DF,Robertson L,et al. Benefits of an inpatient pulmonary rehabilitation program: a prospective analysis. Arch Phys Med Rehabil, 2001,82 : 347-352.
8Pezza M, Iermano C, Tufano R, et al. Nutritional support for the patient with chronic obstructive pulmonary disease. Monaldi Arch Chest Dis, 1994,49:33-39.
